Marcelo Losso

5.4k citations

62 papers · 1.4k · h-index 22

Impact in

Virology top 2%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Infectious Diseases 39
- HIV/AIDS drug development and treatment 26
- HIV/AIDS Research and Interventions 22
Virology 20
- HIV Research and Treatment 18

Co-authors: Jens Lundgren (6 shared papers)Jennifer S. Read (7 shared papers)Sean Emery (6 shared papers)Horacio Salomón (7 shared papers)Andrew Phillips (2 shared papers)Janaki Amin (5 shared papers)Pedro Cahn (7 shared papers)Richard T. Davey (6 shared papers)
Journals: Journal of the International AIDS Society (4 papers)PLoS ONE (4 papers)AIDS Research and Human Retroviruses (4 papers)AIDS (4 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (3 papers)
Partner nations: Argentina United States United Kingdom

In The Last Decade

Marcelo Losso

61 papers receiving 1.4k citations

Peers

Countries citing papers authored by Marcelo Losso

Since Specialization

Citations

This map shows the geographic impact of Marcelo Losso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcelo Losso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcelo Losso more than expected).

Fields of papers citing papers by Marcelo Losso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcelo Losso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcelo Losso. The network helps show where Marcelo Losso may publish in the future.

Co-authors

The 25 scholars most cited alongside Marcelo Losso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marcelo Losso Line = papers co-authored together Marcelo Losso links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus Journal of Virology ·Kazima Saira, Xudong Lin, Jay V. DePasse, Rebecca Halpin, Alan Twaddle, Timothy B. Stockwell, Brian Angus, Alessandro Cozzi‐Lepri, (unknown), Vivien G. Dugan, Dominic E. Dwyer, Matthew S. Freiberg, Andrzej Horban, Marcelo Losso, Ruth Lynfield, Deborah Wentworth, Edward C. Holmes, Richard T. Davey, David E. Wentworth, Elodie Ghedin	2013	133
2	Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial The Lancet Infectious Diseases ·Michael Aboud, Richard Kaplan, Johannes Lombaard, Fujie Zhang, José A. Hidalgo, Elmira Mamedova, Marcelo Losso, Ploenchan Chetchotisakd, Carlos Brites, Jörg Sievers, Dannae Brown, Judy Hopking, Mark Underwood, Maria Cláudia Nascimento, Yogesh Punekar, Martin Gartland, Kimberly Y. Smith	2019	106
3	Infectious Disease Morbidity Among Young HIV-1–Exposed But Uninfected Infants in Latin American and Caribbean Countries: The National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study PEDIATRICS ·Marisa Márcia Mussi‐Pinhata, Laura Freimanis, Aparecida Yulie Yamamoto, James Korelitz, Jorge Pinto, Maria Letícia Santos Cruz, Marcelo Losso, Jennifer S. Read	2007	77
4	Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study The Lancet Infectious Diseases ·(unknown), Dianne Carey, Rebekah Puls, Janaki Amin, Marcelo Losso, Praphan Phanupak, Sharne Foulkes, Lerato Mohapi, Brenda Crabtree‐Ramírez, Heiko Jessen, Suresh Kumar, Alan Winston, Man‐Po Lee, Waldo Belloso, David A. Cooper	2015	76
5	Factors Associated with D-Dimer Levels in HIV-Infected Individuals PLoS ONE ·Álvaro H. Borges, Jemma L. O’Connor, Andrew Phillips, Jason V. Baker, Michael J. Vjecha, Marcelo Losso, Hartwig Klinker, Gustavo Lopardo, Ian Williams, Jens Lundgren	2014	68
6	Pharmacokinetic Parameters of Nevirapine and Efavirenz in Relation to Antiretroviral Efficacy AIDS Research and Human Retroviruses ·Frank van Leth, Bregt S Kappelhoff, David W. Johnson, Marcelo Losso, (unknown), Michael S. Saag, J.‐M. Livrozet, D. B. Hall, Johnathan G Leith, Alwin D. R. Huitema, Ferdinand W N M Wit, Jos H. Beijnen, Joep M. A. Lange	2006	63
7	Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis The Lancet HIV ·Mark Boyd, Cecilia L. Moore, Jean‐Michel Molina, Robin Wood, Juan Sierra Madero, Marcelo Wolff, Kiat Ruxrungtham, Marcelo Losso, Boris Renjifo, Hedy Teppler, Anthony D. Kelleher, Janaki Amin, Sean Emery, David A. Cooper	2015	63
8	Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study Clinical Pharmacology & Therapeutics ·Laura Dickinson, Janaki Amin, Laura Else, Marta Boffito, Deirdre Egan, Andrew Owen, SH Khoo, David Back, Catherine Orrell, Amanda Clarke, Marcelo Losso, Praphan Phanuphak, Dianne Carey, D. A. Cooper, Sean Emery, Rebekah Puls	2015	60
9	A Randomized, Controlled, Phase II Trial Comparing Escalating Doses of Subcutaneous Interleukin‐2 plus Antiretrovirals versus Antiretrovirals Alone in Human Immunodeficiency Virus–Infected Patients with CD4⁺Cell Counts ⩾350/mm³ The Journal of Infectious Diseases ·Marcelo Losso, Waldo Belloso, Sean Emery, Jorge Benetucci, Pedro Cahn, María Lasala, Gustavo Lopardo, Horacio Salomón, Mónica Saracco, (unknown), Matthew Law, Richard T. Davey, Maria C. Allende, H. Clifford Lane	2000	54
10	When should antiretroviral therapy for HIV be started? BMJ ·Andrew Phillips, Brian Gazzard, Nathan Clumeck, Marcelo Losso, Jens Lundgren	2007	49
11	Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata AIDS ·Joanne Reekie, José M. Gatell, Israel Yust, Elżbieta Bąkowska, Aza Rakhmanova, Marcelo Losso, M. Yu. Krasnov, P Francioli, Justyna Kowalska, Amanda Mocroft	2011	47
12	Antiretroviral Adherence During Pregnancy and Postpartum in Latin America AIDS Patient Care and STDs ·Régis Kreitchmann, D.R. Harris, Fabiana Maria Kakehasi, Jessica E. Haberer, Pedro Cahn, Marcelo Losso, Elizabete Teles, José Henrique Pilotto, Cristina Barroso Hofer, for the NISDI Lilac Study Tea Jennifer S. Read	2012	38
13	Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study Clinical Pharmacokinetics ·Laura Dickinson, Janaki Amin, Laura Else, Marta Boffito, Deirdre Egan, Andrew Owen, Saye Khoo, David Back, Catherine Orrell, Amanda Clarke, Marcelo Losso, Praphan Phanuphak, Dianne Carey, David A. Cooper, Sean Emery, Rebekah Puls	2015	38
14	Hepatitis C Virus Coinfection Does Not Influence the CD4 Cell Recovery in HIV-1-Infected Patients With Maximum Virologic Suppression JAIDS Journal of Acquired Immune Deficiency Syndromes ·Lars Peters, Amanda Mocroft, Vincent Soriano, Jürgen K. Rockstroh, Marcelo Losso, Laure Valério, Pauls Aldiņš, Peter Reiss, Bruno Ledergerber, Jens Lundgren	2009	34
15	HIV Type 1 Genetic Diversity Surveillance among Newly Diagnosed Individuals from 2003 to 2005 in Buenos Aires, Argentina AIDS Research and Human Retroviruses ·Darío Dilernia, (unknown), Leonardo Lourtau, Rubén Marone, Marcelo Losso, Horacio Salomón, Manuel Gómez-Carrillo	2007	34
16	Randomized, Controlled Study of the Effects of a Short Course of Prednisone on the Incidence of Rash Associated With Nevirapine in Patients Infected With HIV-1 JAIDS Journal of Acquired Immune Deficiency Syndromes ·Julio Montaner, Pedro Cahn, Carlos Zala, Lidia I. Casssetti, Marcelo Losso, David B. Hall, Jan M. Wruck, Marita McDonough, Maria Gigliotti, Patrick Robinson	2003	34
17	CD4 Cell Response to 3 Doses of Subcutaneous Interleukin 2: Meta-analysis of 3 Vanguard Studies Clinical Infectious Diseases ·Roberto C. Arduino, Esteban C. Nannini, Maria Rodriguez- Barradas, Shannon Schrader, Marcelo Losso, Kiat Ruxrungtham, Maria C. Allende, Sean Emery, Lisa Fosdick, James D. Neaton, Jorge A. Tavel, Richard T. Davey, H. Clifford Lane, (unknown)	2004	31
18	Management of Human Immunodeficiency Virus–Infected Pregnant Women at Latin American and Caribbean Sites Obstetrics and Gynecology ·Jennifer S. Read, Pedro Cahn, Marcelo Losso, Jorge Pinto, Esaú João, Geraldo Duarte, Edmundo Cardoso, Laura Freimanis-Hance, Sonia Stoszek	2007	28
19	Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies PLoS ONE ·Ruth Lynfield, Richard T. Davey, Dominic E. Dwyer, Marcelo Losso, Deborah Wentworth, Alessandro Cozzi‐Lepri, Kathy Herman-Lamin, Grażyna Cholewińska, Daniel David, Stefan Kuetter, Zelalem Ternesgen, Timothy M. Uyeki, H. Clifford Lane, Jens Lundgren, James D. Neaton, (unknown)	2014	26
20	Analysis of HIV Type 1 Diversity in Pregnant Women from Four Latin American and Caribbean Countries AIDS Research and Human Retroviruses ·Manuel Gómez-Carrillo, Sandra Pampuro, Adriana Durán, Marcelo Losso, D.R. Harris, Jennifer S. Read, Geraldo Duarte, Ricardo de Souza, Luis Enrique Soto-Ramírez, Horacio Salomón	2006	23

About Marcelo Losso

Marcelo Losso is a scholar working on Infectious Diseases, Virology, Epidemiology, Emergency Medicine and Public Health, Environmental and Occupational Health, having authored 62 papers that have together received 1.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (26 papers), HIV/AIDS Research and Interventions (22 papers), HIV Research and Treatment (18 papers), HIV-related health complications and treatments (7 papers), Influenza Virus Research Studies (5 papers), Adolescent Sexual and Reproductive Health (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and HIV, Drug Use, Sexual Risk (4 papers). The work is most often cited by research in Virology (392 citations), Infectious Diseases (801 citations), Emergency Medicine (152 citations), Epidemiology (291 citations) and Immunology (117 citations). Marcelo Losso has collaborated with scholars based in Argentina, United States and United Kingdom. Frequent co-authors include Jens Lundgren, Jennifer S. Read, Sean Emery, Horacio Salomón, Andrew Phillips, Janaki Amin, Pedro Cahn, Richard T. Davey, Javier Toibaro and Rebekah Puls. Their work appears in journals such as Journal of the International AIDS Society, PLoS ONE, AIDS Research and Human Retroviruses, AIDS and JAIDS Journal of Acquired Immune Deficiency Syndromes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Marcelo Losso

Impact in

Papers in i

In The Last Decade

Marcelo Losso

Peers

Countries citing papers authored by Marcelo Losso

Fields of papers citing papers by Marcelo Losso

All Works

About Marcelo Losso

Explore authors with similar magnitude of impact

Papers in